BR112021011755A8 - Método para fornecer um benefício de tratamento bucal com o uso de um composto de cálcio de baixa solubilidade e fluoreto - Google Patents

Método para fornecer um benefício de tratamento bucal com o uso de um composto de cálcio de baixa solubilidade e fluoreto

Info

Publication number
BR112021011755A8
BR112021011755A8 BR112021011755A BR112021011755A BR112021011755A8 BR 112021011755 A8 BR112021011755 A8 BR 112021011755A8 BR 112021011755 A BR112021011755 A BR 112021011755A BR 112021011755 A BR112021011755 A BR 112021011755A BR 112021011755 A8 BR112021011755 A8 BR 112021011755A8
Authority
BR
Brazil
Prior art keywords
low solubility
oral treatment
solubility calcium
treatment benefit
fluoride compound
Prior art date
Application number
BR112021011755A
Other languages
English (en)
Other versions
BR112021011755A2 (pt
Inventor
Queiroz Daniel
Tester Chantel
Original Assignee
Johnson & Johnson Consumer Inc
Chenango Zero Llc
Chenango One Llc
Chenango Two Llc
Currahee Holding Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc, Chenango Zero Llc, Chenango One Llc, Chenango Two Llc, Currahee Holding Company Inc filed Critical Johnson & Johnson Consumer Inc
Publication of BR112021011755A2 publication Critical patent/BR112021011755A2/pt
Publication of BR112021011755A8 publication Critical patent/BR112021011755A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/884—Sequential application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

MÉTODO PARA FORNECER UM BENEFÍCIO DE TRATAMENTO BUCAL COM O USO DE UM COMPOSTO DE CÁLCIO DE BAIXA SOLUBILIDADE E FLUORETO. São fornecidos métodos para fornecimento de um benefício à cavidade bucal mediante a administração, à cavidade bucal, de um composto de cálcio de baixa solubilidade e, subsequentemente, a introdução de fluoreto na cavidade bucal.
BR112021011755A 2018-12-17 2019-11-20 Método para fornecer um benefício de tratamento bucal com o uso de um composto de cálcio de baixa solubilidade e fluoreto BR112021011755A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/222,339 2018-12-17
US16/222,339 US11857653B2 (en) 2018-12-17 2018-12-17 Method of providing an oral care benefit using a poorly-soluble calcium compound and fluoride
PCT/IB2019/060001 WO2020128680A1 (en) 2018-12-17 2019-11-20 Method of providing an oral care benefit using a poorly-soluble calcium compound and fluoride

Publications (2)

Publication Number Publication Date
BR112021011755A2 BR112021011755A2 (pt) 2021-08-31
BR112021011755A8 true BR112021011755A8 (pt) 2022-10-11

Family

ID=68732023

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021011755A BR112021011755A8 (pt) 2018-12-17 2019-11-20 Método para fornecer um benefício de tratamento bucal com o uso de um composto de cálcio de baixa solubilidade e fluoreto

Country Status (9)

Country Link
US (1) US11857653B2 (pt)
EP (1) EP3897511A1 (pt)
JP (1) JP2022513979A (pt)
CN (1) CN113271910A (pt)
AU (1) AU2019404124A1 (pt)
BR (1) BR112021011755A8 (pt)
CA (1) CA3123756A1 (pt)
MX (1) MX2021007242A (pt)
WO (1) WO2020128680A1 (pt)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556561A (en) 1983-03-25 1985-12-03 American Dental Association Health Foundation Compositions and methods for topically fluoridating and/or mineralizing dental tissue
JPH08301742A (ja) 1995-04-28 1996-11-19 Ezaki Glico Co Ltd だ液のｐＨ低下を防止する口腔用組成物
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
US9011823B2 (en) 2005-02-01 2015-04-21 Ada Foundation Enhanced anti-carious dentifrices, rinses, lozenges, candies and chewing gums and methods of using same
RU2471475C2 (ru) * 2008-02-08 2013-01-10 Колгейт-Палмолив Компани Продукт для ухода за полостью рта и способы его применения и получения
US9226895B2 (en) 2008-07-30 2016-01-05 Ultradent Products, Inc. Methods and kits for cleaning and remineralizing teeth
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
ES2701018T3 (es) * 2010-04-01 2019-02-20 Procter & Gamble Control del mal olor de toda la boca mediante una combinación de agentes antibacterianos y desodorantes
WO2014124950A1 (en) 2013-02-14 2014-08-21 Glaxo Group Limited Novel composition
US10314771B2 (en) 2013-02-28 2019-06-11 University Of Tennessee Research Foundation Methods and compositions for preventing and treating tooth erosion
US9744108B2 (en) 2013-02-28 2017-08-29 University Of Tennessee Research Foundation Methods and compositions for preventing and treating tooth erosion
AU2015346374A1 (en) 2014-11-11 2017-04-27 Johnson & Johnson Consumer Inc. Amino acid derivatives and their uses
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US11351103B2 (en) 2016-11-18 2022-06-07 Johnson & Johnson Consumer Inc. Method of providing oral care benefits

Also Published As

Publication number Publication date
JP2022513979A (ja) 2022-02-09
BR112021011755A2 (pt) 2021-08-31
WO2020128680A1 (en) 2020-06-25
MX2021007242A (es) 2021-09-23
EP3897511A1 (en) 2021-10-27
US20200188245A1 (en) 2020-06-18
AU2019404124A1 (en) 2021-07-01
US11857653B2 (en) 2024-01-02
CN113271910A (zh) 2021-08-17
CA3123756A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
CL2018000897A1 (es) Composicion de fortalecimiento del cabello y metodo para fortalecer el cabello.
CO2018008207A2 (es) Composiciones para el cuidado bucal y métodos para utilizar las composiciones
CO2018003134A2 (es) Composiciones para el cuidado bucal que comprenden un aminoácido básico, una combinación de fuentes de iones de zinc y un sistema quelante
CY1122648T1 (el) Διαδικασια για την παρασκευη συνθεσεων που περιεχουν υαλουρονικο οξυ και υδροχλωρικη μεπιβακαϊνη
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
AR104984A1 (es) Compuestos selectivos para pyy y sus usos
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
PE20190338A1 (es) Metodos de tratamiento de trastornos del desarrollo con gaboxadol
BR112019001980A2 (pt) inibidor de ido1 e método de preparação e aplicação do mesmo
CL2018000811A1 (es) Formulaciones de aminoácidos de liberación modificada administradas por vía oral.
BR112017022089A2 (pt) uso de uma composição, e, método para branqueamento de dentes
CY1124734T1 (el) Μορφες δοσολογιας αυξητικης ορμονικης μακρας δρασης
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
BR112016024176A2 (pt) composições para tratamento bucal tendo estabilidade aprimorada
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
CL2018000005A1 (es) Composición para el cuidado bucal que comprende silicato de calcio.
CL2019001749A1 (es) Uso de anticuerpos anti-esclerostina en el tratamiento de osteogenesis imperfecta.
CL2021003141A1 (es) Uso de una composición para el cuidado bucal.
CO2021015793A2 (es) Métodos para tratar o prevenir el asma mediante la administración un antagonista de il-33
CO2020005919A2 (es) Compuestos y composiciones farmaceuticas de los mismos para usarse en el tratamiento de enfermedades fibroticas
EA201791600A1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
BR112017024672B8 (pt) Kit de inserção de um implante endósseo unitário
AR116451A1 (es) Administración oral de análogos del péptido glp-1
MX2018004296A (es) Combinacion de un agonista selectivo de il-2rbeta y un agonista il-15 de accion prolongada.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO ONE LLC (US) ; CHENANGO TWO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO ONE LLC (US) ; CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: CHENANGO ONE LLC (US) ; JOHNSON AND JOHNSON CONSUMER INC. (US)

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B25A Requested transfer of rights approved

Owner name: CHENANGO ONE LLC (US) ; JOHNSON AND JOHNSON CONSUMER INC. (US)

B25D Requested change of name of applicant approved

Owner name: CHENANGO ONE LLC (US) ; JOHNSON AND JOHNSON CONSUMER INC. (US)

B25G Requested change of headquarter approved

Owner name: CHENANGO ONE LLC (US) ; JOHNSON AND JOHNSON CONSUMER INC. (US)